Also discussed are major remaining challenges and potential future endeavors toward improving clinical outcomes with rapid bacterial ID/AST technologies.
Rapid bacterial identification ID/AST are in great demand due to the rise of drug-resistant bacteria. Each year, two million people are sickened in the United States with infections resistant to antibiotics. At least 23,000 people die. The development and use of rapid testing technologies for resistant bacteria, that would enable physicians to make the right treatment decision within the critical treatment time span, has been identified as a priority to combat antibiotic resistance. Unfortunately, conventional culture-based methods suffer from a long turnaround time.
In recent years, major advances in miniaturization and automation provide promising solutions for rapid bacterial ID/AST profiling, which will potentially make a significant impact in the clinical management of infectious diseases and antibiotic stewardship.
Source: SLAS (Society for Laboratory Automation and Screening)